OCUP

Ocuphire Pharma (OCUP)

Ocuphire Pharma Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:OCUP

1 2 3 4 5 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/11	05 : 35	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:OCUP	Ocuphire Pharma Inc
2024/05/11	05 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OCUP	Ocuphire Pharma Inc
2024/05/10	21 : 12	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OCUP	Ocuphire Pharma Inc
2024/03/09	07 : 20	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:OCUP	Ocuphire Pharma Inc
2024/03/08	22 : 21	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OCUP	Ocuphire Pharma Inc
2024/02/17	06 : 31	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:OCUP	Ocuphire Pharma Inc
2024/02/17	06 : 03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OCUP	Ocuphire Pharma Inc
2024/02/15	08 : 37	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OCUP	Ocuphire Pharma Inc
2024/02/15	08 : 35	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OCUP	Ocuphire Pharma Inc
2024/02/15	08 : 32	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:OCUP	Ocuphire Pharma Inc
2024/02/15	08 : 29	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:OCUP	Ocuphire Pharma Inc
2024/01/24	14 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:OCUP	Ocuphire Pharma Inc
2024/01/23	08 : 01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OCUP	Ocuphire Pharma Inc
2024/01/23	08 : 01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OCUP	Ocuphire Pharma Inc
2024/01/13	06 : 17	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OCUP	Ocuphire Pharma Inc
2024/01/13	06 : 17	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OCUP	Ocuphire Pharma Inc
2024/01/13	06 : 17	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OCUP	Ocuphire Pharma Inc
2024/01/12	06 : 16	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:OCUP	Ocuphire Pharma Inc
2024/01/11	07 : 00	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:OCUP	Ocuphire Pharma Inc
2024/01/04	08 : 06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OCUP	Ocuphire Pharma Inc
2024/01/04	08 : 04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OCUP	Ocuphire Pharma Inc
2024/01/04	08 : 03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OCUP	Ocuphire Pharma Inc
2024/01/04	07 : 57	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OCUP	Ocuphire Pharma Inc
2023/12/06	06 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OCUP	Ocuphire Pharma Inc
2023/11/27	22 : 45	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OCUP	Ocuphire Pharma Inc
2023/11/14	07 : 46	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OCUP	Ocuphire Pharma Inc
2023/11/14	07 : 42	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OCUP	Ocuphire Pharma Inc
2023/11/13	22 : 48	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:OCUP	Ocuphire Pharma Inc
2023/11/13	22 : 12	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OCUP	Ocuphire Pharma Inc
2023/11/03	22 : 29	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OCUP	Ocuphire Pharma Inc